Simparica Trio 12.5 mg (Pyrantel (Pyrantel Pamoate) TABLET (CHEWABLE)) 12.5 MG

Simparica Trio 12.5 mg chewable tablets provide broad-spectrum parasite protection for dogs. This medication combines pyrantel with other active ingredients to target intestinal worms and fleas. Ideal for pet owners seeking comprehensive parasite control in a convenient chewable form.

Strength

12.5 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Simparica Trio 12.5 mg chewable tablets are designed to help manage and prevent parasitic infestations in dogs. The primary active ingredient, pyrantel, is commonly used for treating and controlling intestinal worms such as roundworms and hookworms. This medication is also effective against fleas, making it a versatile option for pet owners looking to address multiple parasites with a single treatment.

Side Effects

When administered as directed, Simparica Trio 12.5 mg chewable tablets may help reduce the presence of intestinal worms and fleas in dogs. Pet owners may notice improvements in their dog's overall comfort and well-being as the medication works to target these parasites. As with any medication, individual responses can vary.

Precautions & Warnings

Simparica Trio 12.5 mg chewable tablets should be used under the guidance of a veterinarian. It is important to follow the recommended dosage and administration instructions to ensure safety and effectiveness. Pet owners should monitor their dogs for any signs of adverse reactions and consult their veterinarian if concerns arise.

Avoid Interactions

Simparica Trio 12.5 mg chewable tablets may interact with other medications or supplements. It is advisable to inform your veterinarian about any other treatments your dog is receiving to avoid potential interactions. Additionally, some dogs may be more sensitive to certain ingredients, so it is important to use this medication as directed.

Frequently Asked Questions

Simparica Trio 12.5 mg chewable tablets are used to help manage and prevent parasitic infestations in dogs, including intestinal worms and fleas.

Simparica Trio 12.5 mg chewable tablets should be administered orally, following the dosage instructions provided by your veterinarian.

Common effects may include reduced presence of intestinal worms and fleas, leading to improved comfort and well-being in dogs.

Yes, it is important to use Simparica Trio 12.5 mg under veterinary guidance and to monitor your dog for any adverse reactions.

Yes, Simparica Trio 12.5 mg may interact with other medications or supplements, so it is important to inform your veterinarian about any other treatments your dog is receiving.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.